Let’s Talk Optometry: an Evolve Medical Education Podcast en © 2022 Evolve Medical Education LLC. All Rights Reserved. This podcast features content for today’s optometrists, including topics such as dry eye, glaucoma, and retinal disease, among others. Evolve’s podcasts help modern optometrists stay current on important topics in an easy-to-access, on-demand format. https://megaphone.imgix.net/podcasts/fee9822e-cadf-11ec-a0fe-77f9a01f6b1e/image/Optometry_7.png?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress Let’s Talk Optometry: an Evolve Medical Education Podcast no episodic Evolve Medical Education, LLC This podcast features content for today’s optometrists, including topics such as dry eye, glaucoma, and retinal disease, among others. Evolve’s podcasts help modern optometrists stay current on important topics in an easy-to-access, on-demand format. This podcast features content for today’s optometrists, including topics such as dry eye, glaucoma, and retinal disease, among others. Evolve’s podcasts help modern optometrists stay current on important topics in an easy-to-access, on-demand format.

]]> Evolve Medical Education, LLC stephanie@evolvemeded.com Consensus Conversations: Neurotrophic Keratitis: Implementing Best Practices https://evolvemeded.com/course/2318_Video6?utm_source=megaphone&utm_medium=optometry_episode_description Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 30 Apr 2024 00:08:00 -0000 full Evolve Medical Education, LLC Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1713 no Consensus Conversations: Neurotrophic Keratitis: Maintenance Therapy and Investigative Agents https://evolvemeded.com/course/2318_Video5?utm_source=megaphone&utm_medium=optometry_episode_description Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 30 Apr 2024 00:07:00 -0000 full Evolve Medical Education, LLC Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 2030 no Consensus Conversations: Treating Stage 1 Neurotrophic Keratitis https://evolvemeded.com/course/2318_Video4?utm_source=megaphone&utm_medium=optometry_episode_description Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 30 Apr 2024 00:04:00 -0000 full Evolve Medical Education, LLC Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1362 no Diagnosing Retinal Vein Occlusion: A Spectrum of Disease https://evolvemeded.com/course/2325_Cases_6?utm_source=megaphone&utm_medium=episode_description Jessica Steen, OD, FAAO, discusses data from the Score2 clinical trial as well as four cases that highlight how patients with RVOs with macular edema require long-term treatment from a multispeciality team. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here Dr. Steen's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Mon, 11 Mar 2024 16:59:00 -0000 full Evolve Medical Education, LLC Jessica Steen, OD, FAAO, discusses data from the Score2 clinical trial as well as four cases that highlight how patients with RVOs with macular edema require long-term treatment from a multispeciality team. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here Dr. Steen's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Jessica Steen, OD, FAAO, discusses data from the Score2 clinical trial as well as four cases that highlight how patients with RVOs with macular edema require long-term treatment from a multispeciality team.


This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.


Click here Dr. Steen's webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1203 no Thyroid Eye Disease (TED) VideoBytes: From Graves to Gaze https://evolvemeded.com/course/2329_Microlearning-4?utm_source=megaphone&utm_medium=optometry_episode_description In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 23:52:00 -0000 full Evolve Medical Education, LLC In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. In this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that recurred following orbital decompression surgery and presented with diplopia.


This activity is supported by an unrestricted educational grant from Horizon Therapeutics.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 955 no Thyroid Eye Disease (TED) VideoBytes: An Emphasis on Diagnosis https://evolvemeded.com/course/2329_Microlearning-3?utm_source=megaphone&utm_medium=optometry_episode_description Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 23:49:00 -0000 full Evolve Medical Education, LLC Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Join Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED.


This activity is supported by an unrestricted educational grant from Horizon Therapeutics.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 962 no Thyroid Eye Disease (TED) VideoBytes: Managing Chronic TED https://evolvemeded.com/course/2329_Microlearning-2?utm_source=megaphone&utm_medium=optometry_episode_description In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 23:47:00 -0000 full Evolve Medical Education, LLC In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. In this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a case study highlighting the successful use of biologic therapy in managing chronic TED.


This activity is supported by an unrestricted educational grant from Horizon Therapeutics.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 932 no Thyroid Eye Disease (TED) VideoBytes: Delayed Diagnosis of Advanced TED https://evolvemeded.com/course/2329_Microlearning-1?utm_source=megaphone&utm_medium=optometry_episode_description Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Tue, 27 Feb 2024 23:44:00 -0000 full Evolve Medical Education, LLC Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab. This activity is supported by an unrestricted educational grant from Horizon Therapeutics. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six other eye care providers, and was eventually successfully treated with teprotumumab.


This activity is supported by an unrestricted educational grant from Horizon Therapeutics.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 935 no Consensus Conversations: Neurotrophic Keratitis Classification https://evolvemeded.com/course/2318_Video3?utm_source=megaphone&utm_medium=optometry_episode_description Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 27 Dec 2023 20:21:00 -0000 full Evolve Medical Education, LLC Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Classification of neurotrophic keratitis is moving away from the Mackie system. Drs. Nichols and Whitley highlight the Neurotrophic Keratitis Study Group classification system and explain the clinical features of each stage.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1030 no Consensus Conversations: Testing Corneal Sensitivity https://evolvemeded.com/course/2318_Video2?utm_source=megaphone&utm_medium=optometry_episode_description Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, explain why it’s important to perform corneal sensitivity testing on patients suspected of having neurotrophic keratitis and provide tips on best practices.  This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 27 Dec 2023 20:18:00 -0000 full Evolve Medical Education, LLC Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, explain why it’s important to perform corneal sensitivity testing on patients suspected of having neurotrophic keratitis and provide tips on best practices.  This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, explain why it’s important to perform corneal sensitivity testing on patients suspected of having neurotrophic keratitis and provide tips on best practices. 


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 1031 no Consensus Conversations: Neurotrophic Keratitis Prevalence https://evolvemeded.com/course/2318_Video1?utm_source=megaphone&utm_medium=optometry_episode_description Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, present two cases and discuss why neurotrophic keratitis is difficult to diagnose and more prevalent than previously thought. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 27 Dec 2023 20:17:00 -0000 full Evolve Medical Education, LLC Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, present two cases and discuss why neurotrophic keratitis is difficult to diagnose and more prevalent than previously thought. This activity is supported by an unrestricted educational grant from Dompé. Click here to view the webinar event, which includes images from the talk.   Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Kelly K. Nichols, OD, MPH, PhD and Walter O. Whitley, OD, MBA, FAAO, present two cases and discuss why neurotrophic keratitis is difficult to diagnose and more prevalent than previously thought.


This activity is supported by an unrestricted educational grant from Dompé.


Click here to view the webinar event, which includes images from the talk.  


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 994 no Diagnosing Retinal Vein Occlusion: Workup Recommendations for Age 50 & Over and Case Discussion https://evolvemeded.com/course/2325_Cases_5?utm_source=megaphone&utm_medium=episode_description Mark T. Dunbar, OD, FAAO and Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, highlight the workup recommendations for patients 50 years and older suspected of having a retinal vein occlusion (RVO) as well as a case of branch RVO. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 20 Dec 2023 18:09:00 -0000 full Evolve Medical Education, LLC Mark T. Dunbar, OD, FAAO and Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, highlight the workup recommendations for patients 50 years and older suspected of having a retinal vein occlusion (RVO) as well as a case of branch RVO. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Mark T. Dunbar, OD, FAAO and Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, highlight the workup recommendations for patients 50 years and older suspected of having a retinal vein occlusion (RVO) as well as a case of branch RVO.


This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 787 no Diagnosing Retinal Vein Occlusion: Prevalence & Symptoms and Case Discussion https://evolvemeded.com/course/2325_Cases_4?utm_source=megaphone&utm_medium=episode_description Mark T. Dunbar, OD, FAAO and Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, discuss the prevalence and symptoms of retinal vein occlusions (RVOs) as well as a case of branch RVO. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Wed, 20 Dec 2023 18:05:00 -0000 full Evolve Medical Education, LLC Mark T. Dunbar, OD, FAAO and Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, discuss the prevalence and symptoms of retinal vein occlusions (RVOs) as well as a case of branch RVO. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view the webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here. Mark T. Dunbar, OD, FAAO and Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, discuss the prevalence and symptoms of retinal vein occlusions (RVOs) as well as a case of branch RVO.


This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.


Click here to view the webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here.

]]> 953 no First in Class: Emerging Therapies for MGD-Related DED https://evolvemeded.com/course/2317_New_Orleans_Enduring?utm_source=megaphone&utm_medium=episode_description Kelly K. Nichols, OD, MPH, PhD, FAAO, and Walter O. Whitley, OD, MBA, FAAO, discuss how meibomian gland dysfunction interacts with dry eye disease (DED) and summarize the latest clinical and real-world data on new and emerging treatments.  This content was captured during a synchronous in-person and virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Mon, 18 Dec 2023 14:51:00 -0000 full Evolve Medical Education, LLC Kelly K. Nichols, OD, MPH, PhD, FAAO, and Walter O. Whitley, OD, MBA, FAAO, discuss how meibomian gland dysfunction interacts with dry eye disease (DED) and summarize the latest clinical and real-world data on new and emerging treatments.  This content was captured during a synchronous in-person and virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Bausch + Lomb. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Kelly K. Nichols, OD, MPH, PhD, FAAO, and Walter O. Whitley, OD, MBA, FAAO, discuss how meibomian gland dysfunction interacts with dry eye disease (DED) and summarize the latest clinical and real-world data on new and emerging treatments. 


This content was captured during a synchronous in-person and virtual symposium. Polling took place during the symposium.


This activity is supported by an unrestricted educational grant from Bausch + Lomb.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here.

]]> 4598 no Harnessing DED Data: Emerging Therapies, Pipeline, and Cases https://evolvemeded.com/course/2331_Web1_Enduring?utm_source=megaphone&utm_medium=optometry_episode_description Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies as well as the pipeline. Drs. Periman and Brujic also present cases. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Mon, 27 Nov 2023 22:55:00 -0000 full Evolve Medical Education, LLC Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies as well as the pipeline. Drs. Periman and Brujic also present cases. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies as well as the pipeline. Drs. Periman and Brujic also present cases. This content was captured during a live-virtual symposium.


This activity is supported by an unrestricted educational grant from Oyster Point.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here.

]]> 1100 no Harnessing DED Data: New and Emerging Therapies https://evolvemeded.com/course/2331_Web1_Enduring?utm_source=megaphone&utm_medium=optometry_episode_description Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Mon, 27 Nov 2023 22:54:00 -0000 full Evolve Medical Education, LLC Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies. This content was captured during a live-virtual symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Periman talks about a few of the new and emerging dry eye disease therapies. This content was captured during a live-virtual symposium.


This activity is supported by an unrestricted educational grant from Oyster Point.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here.

]]> 1169 no Harnessing DED Data: Comparison Studies https://evolvemeded.com/course/2331_Web1_Enduring?utm_source=megaphone&utm_medium=optometry_episode_description Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Mon, 27 Nov 2023 22:53:00 -0000 full Evolve Medical Education, LLC Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Steen discusses recent comparison studies. This content was captured during a live-virtual symposium. Polling took place during the symposium.


This activity is supported by an unrestricted educational grant from Oyster Point.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here.

]]> 1143 no Harnessing DED Data: Prevalence, Risk Factors, and Diagnostic Tools https://evolvemeded.com/course/2331_Web1_Enduring?utm_source=megaphone&utm_medium=optometry_episode_description Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Brujic highlights dry eye disease’s prevalence, risk factors, and diagnostic tools. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Mon, 27 Nov 2023 22:52:00 -0000 full Evolve Medical Education, LLC Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Brujic highlights dry eye disease’s prevalence, risk factors, and diagnostic tools. This content was captured during a live-virtual symposium. Polling took place during the symposium. This activity is supported by an unrestricted educational grant from Oyster Point. Click here to view the on-demand webinar, which includes images from the talk. Want to register with Evolve Medical Education? Click here.  Join Laura M. Periman, MD; Mile Brujic, OD, FAAO; and Jessica Steen, OD, FAAO, as they discuss dry eye disease. In this podcast, Dr. Brujic highlights dry eye disease’s prevalence, risk factors, and diagnostic tools. This content was captured during a live-virtual symposium. Polling took place during the symposium.


This activity is supported by an unrestricted educational grant from Oyster Point.


Click here to view the on-demand webinar, which includes images from the talk.


Want to register with Evolve Medical Education? Click here. 

]]> 864 no Diagnosing Retinal Vein Occlusion: Managing RVO Risk Factors https://evolvemeded.com/course/2325_Cases_3?utm_source=megaphone&utm_medium=episode_description Steven Ferrucci, OD, FAAO, FORS, highlights two patients who present with multiple risk factors for retinal vein occlusions. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Ferrucci's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.  Wed, 01 Nov 2023 16:57:01 -0000 full Evolve Medical Education, LLC Steven Ferrucci, OD, FAAO, FORS, highlights two patients who present with multiple risk factors for retinal vein occlusions. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Ferrucci's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.  Steven Ferrucci, OD, FAAO, FORS, highlights two patients who present with multiple risk factors for retinal vein occlusions.


This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.


Click here to view Dr. Ferrucci's webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here. 

]]> 1055 no Diagnosing Retinal Vein Occlusion: Exploring the Differential https://evolvemeded.com/course/2325_Cases_2?utm_source=megaphone&utm_medium=episode_description Carolyn E. Majcher, OD, FAAO, FORS, discusses patients with retinal vein occlusions that mimicked other retinal pathologies. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Majcher's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.  Wed, 01 Nov 2023 16:55:10 -0000 full Evolve Medical Education, LLC Carolyn E. Majcher, OD, FAAO, FORS, discusses patients with retinal vein occlusions that mimicked other retinal pathologies. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Majcher's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.  Carolyn E. Majcher, OD, FAAO, FORS, discusses patients with retinal vein occlusions that mimicked other retinal pathologies.


This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.


Click here to view Dr. Majcher's webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here. 

]]> 938 no Diagnosing Retinal Vein Occlusion: The Power of OCTA https://evolvemeded.com/course/2325_Cases_1?utm_source=megaphone&utm_medium=episode_description Carolyn E. Majcher, OD, FAAO, FORS, presents cases that emphasize the importance of systemic evaluation in unusual retinal vein occlusion presentations as well as the utility of multimodal imaging such as OCT angiography. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Majcher's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.  Wed, 01 Nov 2023 16:45:00 -0000 full Evolve Medical Education, LLC Carolyn E. Majcher, OD, FAAO, FORS, presents cases that emphasize the importance of systemic evaluation in unusual retinal vein occlusion presentations as well as the utility of multimodal imaging such as OCT angiography. This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc. Click here to view Dr. Majcher's webinar event, which includes images from the talk. Check out the central hub of this webinar series. Want to register with Evolve Medical Education? Click here.  Carolyn E. Majcher, OD, FAAO, FORS, presents cases that emphasize the importance of systemic evaluation in unusual retinal vein occlusion presentations as well as the utility of multimodal imaging such as OCT angiography.


This activity is supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.


Click here to view Dr. Majcher's webinar event, which includes images from the talk.


Check out the central hub of this webinar series.


Want to register with Evolve Medical Education? Click here. 

]]> 1074 no GA Management: ODs and MDs Take Stock of the Pipeline https://evolvemeded.com/podcasts/lets-talk-optometry Which interventional strategies may lead to positive outcomes for patients with geographic atrophy (GA)? Join Christina Y. Weng, MD, MBA, as she contextualizes select portions of a roundtable moderated by Roger A. Goldberg, MD, MBA. The roundtable included two leading optometrists and two leading retina specialists discussing how complement modulation may be the key to unlocking successful treatment with GA patients. Want to register with Evolve Medical Education? Click here. Mon, 26 Jun 2023 14:45:00 -0000 full Evolve Medical Education, LLC Which interventional strategies may lead to positive outcomes for patients with geographic atrophy (GA)? Join Christina Y. Weng, MD, MBA, as she contextualizes select portions of a roundtable moderated by Roger A. Goldberg, MD, MBA. The roundtable included two leading optometrists and two leading retina specialists discussing how complement modulation may be the key to unlocking successful treatment with GA patients. Want to register with Evolve Medical Education? Click here. Which interventional strategies may lead to positive outcomes for patients with geographic atrophy (GA)? Join Christina Y. Weng, MD, MBA, as she contextualizes select portions of a roundtable moderated by Roger A. Goldberg, MD, MBA. The roundtable included two leading optometrists and two leading retina specialists discussing how complement modulation may be the key to unlocking successful treatment with GA patients.

Want to register with Evolve Medical Education? Click here.

]]> 916 no GA Management: A Candid Discussion With Eye Care Providers https://evolvemeded.com/podcasts/lets-talk-optometry How do leading optometrists and ophthalmologists navigate management of geographic atrophy (GA)? Christina Y. Weng, MD, MBA, guides you as you listen in on a roundtable conversation chaired by Roger A. Goldberg, MD, MBA. During the roundtable, Dr. Goldberg asks a pair of optometrists and a pair of retina specialists which anatomic markers they emphasize during examination of GA patients, explore the disconnect between structure and function in GA patients, and probe which referral patterns may lead to the best patient outcomes. Want to register with Evolve Medical Education? Click here. Mon, 26 Jun 2023 14:30:00 -0000 full Evolve Medical Education, LLC How do leading optometrists and ophthalmologists navigate management of geographic atrophy (GA)? Christina Y. Weng, MD, MBA, guides you as you listen in on a roundtable conversation chaired by Roger A. Goldberg, MD, MBA. During the roundtable, Dr. Goldberg asks a pair of optometrists and a pair of retina specialists which anatomic markers they emphasize during examination of GA patients, explore the disconnect between structure and function in GA patients, and probe which referral patterns may lead to the best patient outcomes. Want to register with Evolve Medical Education? Click here. How do leading optometrists and ophthalmologists navigate management of geographic atrophy (GA)? Christina Y. Weng, MD, MBA, guides you as you listen in on a roundtable conversation chaired by Roger A. Goldberg, MD, MBA. During the roundtable, Dr. Goldberg asks a pair of optometrists and a pair of retina specialists which anatomic markers they emphasize during examination of GA patients, explore the disconnect between structure and function in GA patients, and probe which referral patterns may lead to the best patient outcomes.

Want to register with Evolve Medical Education? Click here.

]]> 964 no Mapping Out a Strategy: Diagnostic Tools and Possible Therapies for Geographic Atrophy https://www.evolvemeded.com/course/2227_GA_Enduring This podcast, which took place prior to the approval of pegcetacoplan, features Drs. Sadda, Modi, and Baumal discussing the newly approved and potential therapies as well as risk factors that drive the disease, imaging modalities that are best suited for GA evaluation, and the type of lesion patterns that place patients at high risk for progression. This activity is supported by an unrestricted medical educational grant from Apellis Pharmaceuticals. Click here to view this webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here. Mon, 22 May 2023 15:09:00 -0000 full Evolve Medical Education, LLC This podcast, which took place prior to the approval of pegcetacoplan, features Drs. Sadda, Modi, and Baumal discussing the newly approved and potential therapies as well as risk factors that drive the disease, imaging modalities that are best suited for GA evaluation, and the type of lesion patterns that place patients at high risk for progression. This activity is supported by an unrestricted medical educational grant from Apellis Pharmaceuticals. Click here to view this webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here. This podcast, which took place prior to the approval of pegcetacoplan, features Drs. Sadda, Modi, and Baumal discussing the newly approved and potential therapies as well as risk factors that drive the disease, imaging modalities that are best suited for GA evaluation, and the type of lesion patterns that place patients at high risk for progression.


This activity is supported by an unrestricted medical educational grant from Apellis Pharmaceuticals.


Click here to view this webinar event, which includes images from the talk.


Want to register with Evolve Medical Education? Click here.

]]> 4583 no